Dr. Reddy’s launches Sevelamer Carbonate for Oral Suspension in US Market
Dr. Reddy’s Laboratories has launched Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for Oral Suspension, approved by the U.S. Food and Drug Administration (USFDA). The Renvela brand and generic had U.S. sales of approximately $101 million MAT for the most recent … Read more
